LIVER TRANSPLANTATION
Clinical trials for LIVER TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new LIVER TRANSPLANTATION trials appear
Sign up with your email to follow new studies for LIVER TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
UCLA pioneers 'Delayed Tolerance' to end lifelong drug use after liver transplant
Disease control Recruiting nowThis study tests whether a donor stem cell infusion, given after a mild radiation and antibody treatment, can train the immune system to accept a liver transplant without needing lifelong anti-rejection drugs. Up to 12 adults who have had a well-functioning liver transplant from …
Matched conditions: LIVER TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated May 01, 2026 15:27 UTC
-
Liver transplant drug showdown: which lowers pressure better?
Disease control Recruiting nowThis study compares two drugs, terlipressin and somatostatin, to see which better lowers high blood pressure in the liver's main vein during a living-donor liver transplant. High pressure can cause dangerous bleeding, so finding the best drug may improve safety. About 50 adults w…
Matched conditions: LIVER TRANSPLANTATION
Phase: NA • Sponsor: Istanbul Medipol University Hospital • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
One pill a day? new study aims to simplify life after liver transplant
Disease control Recruiting nowThis study tests whether giving immunosuppressive drugs as a single daily dose after a liver transplant works as well as the standard twice-daily dosing. About 162 liver transplant recipients will be followed for one year to compare treatment failure, adherence, and quality of li…
Matched conditions: LIVER TRANSPLANTATION
Phase: PHASE4 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC